Precision Medicine Approaches as the Next Step to Account for Alzheimer’s & Parkinson’s Disease Heterogeneity & Patient Specificity
Time: 3:30 pm
day: Conference Day Two
Details:
- Harnessing multi-omic and GWAS data to identify the range of genetic markers and risk factors contributing to the heterogeneity of Alzheimer’s and Parkinson’s disease
- Strategizing on how personalized treatment plans targeting specific disease subtypes and characteristics can optimize effectiveness of interventions and slow disease progression
- Highlighting the potential of precision medicine to bridge the gap between research and clinical practice by offering insights into how genetic and molecular profiling can guide treatment decisions, improving patient outcomes and enhancing drug development efforts
